Concurrent Investment Advisors LLC Purchases 731 Shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Concurrent Investment Advisors LLC raised its position in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 18.7% in the 2nd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 4,639 shares of the company’s stock after purchasing an additional 731 shares during the period. Concurrent Investment Advisors LLC’s holdings in GE HealthCare Technologies were worth $362,000 as of its most recent filing with the SEC.

Several other large investors have also recently bought and sold shares of GEHC. Wynn Capital LLC increased its position in shares of GE HealthCare Technologies by 4.1% during the first quarter. Wynn Capital LLC now owns 3,125 shares of the company’s stock worth $284,000 after acquiring an additional 122 shares in the last quarter. Fiduciary Trust Co increased its position in shares of GE HealthCare Technologies by 1.8% during the fourth quarter. Fiduciary Trust Co now owns 7,696 shares of the company’s stock worth $595,000 after acquiring an additional 133 shares in the last quarter. Quent Capital LLC increased its position in shares of GE HealthCare Technologies by 21.3% during the first quarter. Quent Capital LLC now owns 780 shares of the company’s stock worth $71,000 after acquiring an additional 137 shares in the last quarter. Tempus Wealth Planning LLC increased its position in shares of GE HealthCare Technologies by 0.5% during the second quarter. Tempus Wealth Planning LLC now owns 30,892 shares of the company’s stock worth $2,407,000 after acquiring an additional 141 shares in the last quarter. Finally, Wealthspire Advisors LLC increased its position in shares of GE HealthCare Technologies by 2.8% during the first quarter. Wealthspire Advisors LLC now owns 5,373 shares of the company’s stock worth $488,000 after acquiring an additional 147 shares in the last quarter. Institutional investors own 82.06% of the company’s stock.

Insider Activity

In related news, CEO Thomas J. Westrick sold 2,750 shares of the firm’s stock in a transaction dated Wednesday, August 7th. The shares were sold at an average price of $80.78, for a total transaction of $222,145.00. Following the transaction, the chief executive officer now directly owns 17,509 shares of the company’s stock, valued at $1,414,377.02. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. 0.27% of the stock is currently owned by company insiders.

GE HealthCare Technologies Stock Performance

Shares of NASDAQ GEHC opened at $84.80 on Wednesday. The company has a current ratio of 1.06, a quick ratio of 0.82 and a debt-to-equity ratio of 1.05. The stock has a 50 day moving average of $81.59 and a 200-day moving average of $83.47. GE HealthCare Technologies Inc. has a 12 month low of $62.35 and a 12 month high of $94.50. The company has a market capitalization of $38.71 billion, a P/E ratio of 24.80, a P/E/G ratio of 3.17 and a beta of 1.17.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its earnings results on Wednesday, July 31st. The company reported $1.00 EPS for the quarter, beating the consensus estimate of $0.98 by $0.02. The company had revenue of $4.84 billion for the quarter, compared to the consensus estimate of $4.88 billion. GE HealthCare Technologies had a return on equity of 25.26% and a net margin of 8.10%. The firm’s revenue for the quarter was up .5% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.92 earnings per share. As a group, equities research analysts predict that GE HealthCare Technologies Inc. will post 4.26 EPS for the current year.

GE HealthCare Technologies Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Thursday, August 15th. Stockholders of record on Friday, July 19th were issued a dividend of $0.03 per share. This represents a $0.12 dividend on an annualized basis and a dividend yield of 0.14%. The ex-dividend date of this dividend was Friday, July 19th. GE HealthCare Technologies’s dividend payout ratio is currently 3.51%.

Analyst Ratings Changes

GEHC has been the subject of a number of analyst reports. The Goldman Sachs Group initiated coverage on shares of GE HealthCare Technologies in a research report on Thursday, May 30th. They issued a “neutral” rating and a $87.00 target price for the company. Stifel Nicolaus initiated coverage on shares of GE HealthCare Technologies in a research report on Tuesday, August 6th. They issued a “buy” rating and a $100.00 target price for the company. Finally, Redburn Atlantic raised shares of GE HealthCare Technologies to a “strong-buy” rating in a research report on Thursday, August 1st. Five analysts have rated the stock with a hold rating, six have assigned a buy rating and one has given a strong buy rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $95.00.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.